Table 6.
Relapse-Free Survival | Cancer-Specific Survival | Overall Survival | |||||||
---|---|---|---|---|---|---|---|---|---|
Characteristic | HR | 95% CI | p-value | HR | 95% CI | p-value | HR | 95% CI | p-value |
PIV (Reference: low) | |||||||||
High | 1.74 | 1.04, 2.92 | 0.034 | 1.30 | 0.69, 2.43 | 0.412 | 1.58 | 1.00, 2.49 | 0.048 |
Age | 0.99 | 0.52, 1.88 | 0.994 | 1.46 | 0.61, 3.49 | 0.387 | 1.21 | 0.67, 2.21 | 0.517 |
Smoking status (Reference: no) | |||||||||
Smoke | 1.26 | 0.72, 2.19 | 0.403 | 2.13 | 1.02, 4.44 | 0.043 | 1.73 | 1.02, 2.92 | 0.039 |
Sex (Reference: male) | |||||||||
Female | 1.42 | 0.77, 2.61 | 0.258 | 1.78 | 0.92, 3.45 | 0.084 | 1.30 | 0.77, 2.18 | 0.314 |
Tumor grading | |||||||||
(Reference: pT0/pTa/pTispT1) | |||||||||
pT2 | 1.67 | 0.65, 4.28 | 0.283 | 0.98 | 0.31, 3.11 | 0.981 | 1.54 | 0.70, 3.40 | 0.276 |
pT3/pT4 | 2.84 | 1.14, 7.09 | 0.025 | 2.88 | 1.17, 7.11 | 0.021 | 3.23 | 1.59, 6.53 | 0.001 |
Lymphovascular invasion | 1.03 | 0.41, 2.54 | 0.94 | 0.97 | 0.38, 2.44 | 0.957 | 0.90 | 0.44, 1.81 | 0.774 |
Lymph node invasion | 3.85 | 2.12, 6.99 | <0.001 | 4.26 | 1.89, 9.61 | <0.001 | 3.12 | 1.74, 5.60 | <0.001 |
Adjuvant chemotherapy | 1.31 | 0.73, 2.34 | 0.349 | 0.44 | 0.19, 1.00 | 0.05 | 0.61 | 0.34, 1.08 | 0.092 |
C-index | |||||||||
Model with PIV | 0.78 | 0.76 | 0.73 | ||||||
Model without PIV | 0.77 (+1%) | 0.76 | 0.72 (1%) | ||||||
(p = difference model) | 0.03 | 0.67 | 0.04 |
PIV = Pan-immune inflammation value; HR = Hazard ratio; CI = Confidence Interval.